Back
Pacira BioSciences Vs. Karyopharm Therapeutics Industry Stock Comparison
Buy
57
PCRX
Pacira BioSciences
Last Price:
30.79
Seasonality Move:
7.59%
Buy
61
KPTI
Karyopharm Therapeutics
Last Price:
1.15
Seasonality Move:
-4.13%
Buy
57
Pacira BioSciences (PCRX)
is a Buy
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $30.82. The Score for PCRX is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
- PCRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Karyopharm Therapeutics (KPTI)
is a Buy
Is Karyopharm Therapeutics a Buy, Sell or Hold?
- The current Karyopharm Therapeutics [KPTI] share price is $1.15. The Score for KPTI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
- KPTI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $30.82
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.
KPTI Stock Price Chart
What is Karyopharm Therapeutics's stock price today?
-
The Karyopharm Therapeutics share price today is $1.15
The current trend is relatively stagnant and KPTI is experiencing slight selling pressure.
PCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 62.81 | Buy |
| Chaikin Money Flow: | -360300 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (25.83 - 29.57) | Buy |
| Bollinger Bands (100): | (27.58 - 32.1) | Buy |
KPTI Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 50.12 | Buy |
| Chaikin Money Flow: | -359886 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.05 - 1.19) | Buy |
| Bollinger Bands (100): | (0.92 - 1.4) | Sell |
PCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 30.32 | Buy |
| 20-day SMA: | 28 | Buy |
| 50-day SMA: | 28.39 | Buy |
| 200-day SMA: | 30.72 | Buy |
| 8-day EMA: | 30.06 | Buy |
| 20-day EMA: | 28.85 | Buy |
| 50-day EMA: | 28.63 | Buy |
| 200-day EMA: | 31.56 | Sell |
KPTI Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.1 | Buy |
| 20-day SMA: | 1.09 | Buy |
| 50-day SMA: | 1.26 | Sell |
| 200-day SMA: | 1.14 | Buy |
| 8-day EMA: | 1.12 | Buy |
| 20-day EMA: | 1.13 | Buy |
| 50-day EMA: | 1.18 | Sell |
| 200-day EMA: | 1.43 | Sell |
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.10 per share, an increase next quarter of $0.25 per share, a decrease this year of $0.14 per share, and an increase next year of $0.80 per share.
Karyopharm Therapeutics Earnings Growth & KPTI Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.02 per share, and an increase next year of $0.34 per share.
Pacira BioSciences Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Karyopharm Therapeutics Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||